"Estrogen dominance" is a term you may see online for estrogen that's high compared with progesterone. It isn't an established diagnosis, and we found no guideline that defines it or sets a ratio to test for it.
What Is Estrogen Dominance?
People may use the term when:
- Estrogen is elevated
- Progesterone is too low
- Or both
Research gives this idea limited support:
- A small urine study of 11 women around perimenopause found higher estrogen breakdown products and lower luteal progesterone breakdown products than in younger women (Santoro et al., 1996)
- A larger study of women over 42 found lower progesterone breakdown products, but estrogen breakdown products that did not differ from younger women's (Santoro et al., 2004)
- Hormones in the transition to menopause can be erratic and unpredictable (Burger et al., 2008)
- In regularly menstruating women, cycles with a short luteal phase or low luteal progesterone were found to have lower estradiol, not higher (Schliep et al., 2014)
Symptoms People Link to It
- Heavy or painful periods
- PMS and mood swings
- Breast tenderness
- Weight gain
- Bloating and water retention
- Headaches, especially premenstrual
- Anxiety and irritability
These symptoms can have many causes, and research hasn't shown that an estrogen-to-progesterone ratio explains them. A pilot study of 14 women with migraine found that menstrual distress can go along with a higher ratio, but the ratio was no more closely related to it than either hormone alone (Beckham et al., 1992). In a study of women with menstrually related mood symptoms, progesterone and estradiol levels and patterns did not differ from those of controls (Rubinow et al., 1988).
Fibroids and endometriosis are medical conditions a clinician can diagnose and treat. See a clinician about heavy or painful periods. If your mood has been low, get help now. Treatment for low mood doesn't need to wait for a lab test.
What Can Shift Estrogen and Progesterone?
- Cycles without ovulation: No ovulation can mean no rise in progesterone after mid-cycle. In one study of women over 42, about 19% of cycles showed no sign of luteal activity (Santoro et al., 2004)
- Perimenopause: Cycles without ovulation can become more frequent in the last 30 months before the final period (Burger et al., 2008)
- Body fat: Fat tissue can turn androgens into estrogens (Lee & Den Hartigh, 2025)
- Plant estrogens: These can act as weak estrogens or block estrogen, much like BPA, but whether they help or harm remains unresolved (Patisaul & Jefferson, 2010)
Can a Lab Test Show It?
We found no guideline that sets an estrogen-to-progesterone ratio to test. Estradiol and progesterone can vary widely between cycles in the same woman (Stricker et al., 2006), so one result can't show a lasting imbalance.
When to Test
If a clinician orders a progesterone test to check for ovulation, timing matters. A reference study set the mid-luteal phase at 5 to 9 days after the LH peak (Stricker et al., 2006), so the right day can depend on your cycle length.
Supporting Tests
For abnormal bleeding, the workup can include a history, pelvic exam, pregnancy test and complete blood count. A clinician may also sample the uterine lining if you're 45 or older, or if you're younger with a significant history of estrogen exposure without progesterone to balance it (Wouk & Helton, 2019). Your clinician can decide whether other tests make sense.
References
- Santoro, N., et al. (2004). Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. Journal of Clinical Endocrinology & Metabolism, 89(6), 2622-2631. PMID 15181033
- Patisaul, H. B., & Jefferson, W. (2010). The pros and cons of phytoestrogens. Frontiers in Neuroendocrinology, 31(4), 400-419. PMID 20347861
- Santoro, N., et al. (1996). Characterization of reproductive hormonal dynamics in the perimenopause. Journal of Clinical Endocrinology & Metabolism, 81(4), 1495-1501. PMID 8636357
- Burger, H. G., et al. (2008). Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause, 15(4 Pt 1), 603-612. PMID 18574431
- Schliep, K. C., et al. (2014). Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria. Journal of Clinical Endocrinology & Metabolism, 99(6), E1007-14. PMID 24606080
- Rubinow, D. R., et al. (1988). Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. American Journal of Obstetrics and Gynecology, 158(1), 5-11. PMID 2962499
- Lee, A. A., et al. (2025). Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan. Frontiers in Endocrinology, 16, 1682231. PMID 41180177
- Stricker, R., et al. (2006). Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clinical Chemistry and Laboratory Medicine, 44(7), 883-887. PMID 16776638
- Wouk, N., et al. (2019). Abnormal Uterine Bleeding in Premenopausal Women. American Family Physician, 99(7), 435-443. PMID 30932448
- Beckham, J. C., et al. (1992). The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. Headache, 32(6), 292-297. PMID 1399550



